Neuronal Circuitry Underlying the Impact of D3 Receptor Ligands in Drug Addiction

Overview

Journal Eur Neuropsychopharmacol

Publisher Elsevier

Specialties Pharmacology
Psychiatry

Date 2014 Oct 1

PMID 25266821

Citations 10

Authors

Bernard Le Foll

Patricia Di Ciano

Affiliations

Soon will be listed here.

Abstract

Since the cloning of the D3 receptor in the early 1990s, there has been a great deal of interest in this receptor as a possible therapeutic target for drug addiction. The development of a D3 ligand suitable for use in humans has remained elusive, so the study of the function of the D3 receptor and its possible therapeutic efficacy has largely been restricted to animals. Pre-clinical studies have established that systemic administration of D3 ligands, particularly antagonists and partial agonists, can alter drug-seeking in animals. Despite over a decade of research, few studies have investigated the effects of intra-cerebral infusion of D3 ligands on drug-seeking. In the present review, these studies are summarized, which have largely focused on stimulus-controlled behaviors. Converging evidence from studies of D3 receptor expression, Fos and pharmacological Magnetic Resonance Imaging (phMRI) is also provided to delineate some of the D3 brain systems involved in drug-seeking and taking. The data so far indicate that different brain systems may be involved in different types of stimulus control as well as drug taking.

Citing Articles

Selective D3 receptor antagonism modulates neural response during negative emotional processing in substance dependence.

Vamvakopoulou I, Fonville L, Hayes A, McGonigle J, Elliott R, Ersche K Front Psychiatry. 2022; 13:998844.

PMID: 36339857 PMC: 9627287. DOI: 10.3389/fpsyt.2022.998844.

Dopamine D3 receptor-based medication development for the treatment of opioid use disorder: Rationale, progress, and challenges.

Galaj E, Newman A, Xi Z Neurosci Biobehav Rev. 2020; 114:38-52.

PMID: 32376243 PMC: 7252042. DOI: 10.1016/j.neubiorev.2020.04.024.

Pharmacological evidence that 5-HT receptor blockade selectively improves decision making when rewards are paired with audiovisual cues in a rat gambling task.

Adams W, Barkus C, Ferland J, Sharp T, Winstanley C Psychopharmacology (Berl). 2017; 234(20):3091-3104.

PMID: 28733811 DOI: 10.1007/s00213-017-4696-4.

A Molecular Basis for Selective Antagonist Destabilization of Dopamine D Receptor Quaternary Organization.

Marsango S, Caltabiano G, Jimenez-Roses M, Millan M, Pediani J, Ward R Sci Rep. 2017; 7(1):2134.

PMID: 28522847 PMC: 5437050. DOI: 10.1038/s41598-017-02249-3.

Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence.

Murphy A, Nestor L, McGonigle J, Paterson L, Boyapati V, Ersche K Neuropsychopharmacology. 2017; 42(5):1049-1057.

PMID: 28042871 PMC: 5423526. DOI: 10.1038/npp.2016.289.

References

Leggio G, Camillieri G, Platania C, Castorina A, Marrazzo G, Torrisi S . Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone. Neuropsychopharmacology. 2014; 39(8):2017-28. PMC: 4059912. DOI: 10.1038/npp.2014.51. View

Roberts C, Cummins R, Gnoffo Z, Kew J . Dopamine D3 receptor modulation of dopamine efflux in the rat nucleus accumbens. Eur J Pharmacol. 2006; 534(1-3):108-14. DOI: 10.1016/j.ejphar.2006.01.014. View

Khaled M, Araki K, Li B, Coen K, Marinelli P, Varga J . The selective dopamine D3 receptor antagonist SB 277011-A, but not the partial agonist BP 897, blocks cue-induced reinstatement of nicotine-seeking. Int J Neuropsychopharmacol. 2009; 13(2):181-90. DOI: 10.1017/S1461145709991064. View

Ehrman R, Robbins S, Childress A, OBrien C . Conditioned responses to cocaine-related stimuli in cocaine abuse patients. Psychopharmacology (Berl). 1992; 107(4):523-9. DOI: 10.1007/BF02245266. View

Ashby Jr C, Paul M, Gardner E, Heidbreder C, Hagan J . Acute administration of the selective D3 receptor antagonist SB-277011A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats. Synapse. 2003; 48(3):154-6. DOI: 10.1002/syn.10188. View

Neisewander J, ODell L, Castaneda E, Fuchs R . Dopamine overflow in the nucleus accumbens during extinction and reinstatement of cocaine self-administration behavior. Neuropsychopharmacology. 1996; 15(5):506-14. DOI: 10.1016/S0893-133X(96)00097-8. View

Hitchcott P, Phillips G . Effects of intra-amygdala R(+) 7-OH-DPAT on intra-accumbens d-amphetamine-associated learning. II. Instrumental conditioning. Psychopharmacology (Berl). 1999; 140(3):310-8. DOI: 10.1007/s002130050772. View

Gyertyan I, Gal K . Dopamine D3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference. Neuroreport. 2003; 14(1):93-8. DOI: 10.1097/00001756-200301200-00018. View

Di Ciano P, Underwood R, Hagan J, Everitt B . Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A. Neuropsychopharmacology. 2003; 28(2):329-38. DOI: 10.1038/sj.npp.1300148. View

10.

Duarte C, Lefebvre C, Chaperon F, Hamon M, Thiebot M . Effects of a dopamine D3 receptor ligand, BP 897, on acquisition and expression of food-, morphine-, and cocaine-induced conditioned place preference, and food-seeking behavior in rats. Neuropsychopharmacology. 2003; 28(11):1903-15. DOI: 10.1038/sj.npp.1300276. View

11.

Le Foll B, Goldberg S, Sokoloff P . The dopamine D3 receptor and drug dependence: effects on reward or beyond?. Neuropharmacology. 2005; 49(4):525-41. DOI: 10.1016/j.neuropharm.2005.04.022. View

12.

Heidbreder C, Andreoli M, Marcon C, Hutcheson D, Gardner E, Ashby Jr C . Evidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice. Addict Biol. 2007; 12(1):35-50. DOI: 10.1111/j.1369-1600.2007.00051.x. View

13.

Vorel S, Ashby Jr C, Paul M, Liu X, Hayes R, Hagan J . Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci. 2002; 22(21):9595-603. PMC: 6758043. View

14.

Goldberg S, Kelleher R . Behavior controlled by scheduled injections of cocaine in squirrel and rhesus monkeys. J Exp Anal Behav. 1976; 25(1):93-104. PMC: 1333419. DOI: 10.1901/jeab.1976.25-93. View

15.

Le Foll B, Frances H, Diaz J, Schwartz J, Sokoloff P . Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice. Eur J Neurosci. 2002; 15(12):2016-26. DOI: 10.1046/j.1460-9568.2002.02049.x. View

16.

Sokoloff P, Giros B, Martres M, Bouthenet M, Schwartz J . Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 1990; 347(6289):146-51. DOI: 10.1038/347146a0. View

17.

McCormick P, Wilson V, Wilson A, Remington G . Acutely administered antipsychotic drugs are highly selective for dopamine D2 over D3 receptors. Pharmacol Res. 2013; 70(1):66-71. DOI: 10.1016/j.phrs.2013.01.002. View

18.

Gurevich E, Joyce J . Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons. Neuropsychopharmacology. 1999; 20(1):60-80. DOI: 10.1016/S0893-133X(98)00066-9. View

19.

Fowler C, Lu Q, Johnson P, Marks M, Kenny P . Habenular α5 nicotinic receptor subunit signalling controls nicotine intake. Nature. 2011; 471(7340):597-601. PMC: 3079537. DOI: 10.1038/nature09797. View

20.

Higley A, Kiefer S, Li X, Gaal J, Xi Z, Gardner E . Dopamine D(3) receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats. Eur J Pharmacol. 2011; 659(2-3):187-92. PMC: 3728376. DOI: 10.1016/j.ejphar.2011.02.046. View